Cleaning Systems, Inc. - Laserfiche WebLink

Home Browse Search

B. INFORMED CONSENT AND RELEASE OF LIABILITY FORM The execution of an "Informed Consent and Release of Liability (Testing /Release of Results)" form will be required of each applicant /employee submitting to a drug test. Refusal to comply will result in the applicant's & isqualification for further employment consideration, or the employee's termination from the Company's employment. C. REFUSAL TO SUBMIT TO TESTING Job applicants and employees are expected to cooperate fully in providing specimens and explanations which may be subsequently required by this Policy. Failure to provide specimens, attempts to contaminate specimensor otherwise interfere with Company procedures will be grounds for disciplinary action up to and including discharge or disqualification for further employment consideration. An employee who is injured in the course and scope of his employment and who refuses to submit to a drug test, or who tests positive, in addition to the above, forfeits his or her eligibility for Florida Workers' Compensation medical and Indemnity benefits. Any company group health /medical insurance in effect does not cover injuries sustained in the course and scope of employment. VII. TESTING PROCEDURES A. HRS- LICENSED LABORATORY All drug testing will be conducted by a Company- designated laboratory which is licensed by the State of Florida Department of Health and Rehabilitative Services (HRS). The testing will be conducted with appropriate chain of custody procedures in place to ensure accuracy and continuity in specimen collection, handling, transfer and storage. B. DRUGS TO BE TESTED When testing is conducted in conjunction with this program CSI may test for any or all of the following drugs: amphetamines, barbiturates, benzodiazepines, cannanbinoids, cocaine, ethyl alcohol, methadone, methaqualone, �piates, phencyclidine, and propoxphene. C. REPORTING MEDICATION WHICH MAY ALTER OR AFFECT A DRUG TEST RESULT 1. Each applicant /employee shall be provided a form entitled "Pre- -and Post - Testing Report of Use of Medication" which will enable them to report, both before and after being tested, the use of prescription or non- prescription medication which may alter or affect the outcome of a drug test as well as any other information relevant to the drug test result. The reverse side of the above referenced form shall contain a list, developed by HRS of the most common medications, by brand name or common name, as well as by chemical name, which may alter or affect a drug test result. The information provided by the employee or job applicant shall be reviewed by a Medical Review Officer (MRO) interpreting any confirmed positive results. 2. Job applicants and employees have the right to consult the Company- designated, HRS- licensed laboratory for technical information regarding prescription and non - prescription drugs. D. COST OF TESTING CSI, shall pay the costs of initial and confirmation drug testing which it requires of both job applicants and employees. Applicants and employees shall pay the cost of any additional drug testing not required by the Company. E. COLLECTION SITE AND LABORATORY ANALYSIS PROCEDURES Security of the collection site, chain of custody procedures, privacy of the individual, collection control, integrity and identity of the specimen and transportation of the specimen to the laboratory, as well as all laboratory security, laboratory chain of custody, transporting and receiving of specimens, specimen processing, retesting, storage of specimens, instrument calibration and reporting of results, shall be in accordance with 112.0455 (F.S.), and its attendant *les as established by the Department of Health and Rehabilitive Services in F.A.C., Ch. 10E -18. These procedures are tended to ensure that specimens are properly collected, identified and tested. 3